首页 > 最新文献

European Medical Journal (Chelmsford, England)最新文献

英文 中文
Interview: Aurore Girard 采访:欧罗·吉拉德
Pub Date : 2023-09-12 DOI: 10.33590/emj/10302075
Aurore Girard
{"title":"Interview: Aurore Girard","authors":"Aurore Girard","doi":"10.33590/emj/10302075","DOIUrl":"https://doi.org/10.33590/emj/10302075","url":null,"abstract":"","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135886560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Evidence-Based Dietary Interventions for the Management of Obesity 基于证据的饮食干预在肥胖管理中的应用
Pub Date : 2023-09-08 DOI: 10.33590/emj/10302068
L Busetto, F Casanueva, J Ard, B Van der Schueren, B Burguera
Obesity has become a serious public health issue worldwide, with its prevalence steadily increasing. The potential consequences of this chronic disease, including cardiovascular disease, increased morbidity, and mortality, pose a significant burden on individuals and healthcare systems. Evidence has established that lifestyle and dietary modification are central to achieving effective weight loss. One approach shown to be efficacious in achieving weight loss is the use of a very low calorie ketogenic diet (VLCKD), which includes stages of induced ketosis, followed by a reintroduction to a low calorie diet and maintenance diet. Such regimens have been shown to result in sustained weight loss and, for some people, remission of Type 2 diabetes (T2D). A similar approach, which may also be a component of the VLCKD, is the use of total or partial replacement of meals using nutritionally complete shakes, bars, or soups. These may be combined with other weight loss measures, including bariatric surgery or medications. It is important that such programmes are delivered in a structured, medically-monitored, and supportive environment, such as laid out by Obesity Canada’s ‘5As’ programme. An ‘obesity shared medical appointment’ model is a multidisciplinary approach, whereby a patient with obesity is seen by a number of healthcare specialists, depending on their comorbidities. The patient also has the opportunity to meet with obesity specialists and engage in monthly patient support groups, all of which have been shown to be successful interventions in helping patients lead a healthier lifestyle, and gain more control over their weight. The following proceedings are based on talks given by leading obesity experts, presented at the 30th European Congress on Obesity (ECO 2023), which took place in Dublin, Republic of Ireland, in May 2023.
肥胖已成为世界范围内严重的公共卫生问题,其患病率稳步上升。这种慢性疾病的潜在后果,包括心血管疾病,发病率和死亡率的增加,对个人和卫生保健系统构成了重大负担。有证据表明,改变生活方式和饮食习惯是实现有效减肥的关键。一种被证明对减肥有效的方法是使用极低卡路里生酮饮食(VLCKD),包括诱导酮症的阶段,然后重新引入低卡路里饮食和维持饮食。这样的治疗方案已被证明能导致持续的体重减轻,对一些人来说,还能缓解2型糖尿病(T2D)。一个类似的方法,也可能是VLCKD的一个组成部分,是使用营养完整的奶昔,棒或汤来完全或部分替代膳食。这些可能与其他减肥措施相结合,包括减肥手术或药物。重要的是,这些方案必须在结构化、医学监测和支持性的环境中实施,如加拿大肥胖局的" 5a "方案所规定的那样。“肥胖共享医疗预约”模式是一种多学科的方法,根据患者的合并症,肥胖患者由多名医疗保健专家进行诊治。患者还有机会与肥胖专家会面,并参加每月的患者支持小组,所有这些都已被证明是成功的干预措施,有助于患者过上更健康的生活方式,并更好地控制体重。以下会议记录是根据2023年5月在爱尔兰共和国都柏林举行的第30届欧洲肥胖大会(ECO 2023)上主要肥胖专家的演讲整理的。
{"title":"The Use of Evidence-Based Dietary Interventions for the Management of Obesity","authors":"L Busetto, F Casanueva, J Ard, B Van der Schueren, B Burguera","doi":"10.33590/emj/10302068","DOIUrl":"https://doi.org/10.33590/emj/10302068","url":null,"abstract":"Obesity has become a serious public health issue worldwide, with its prevalence steadily increasing. The potential consequences of this chronic disease, including cardiovascular disease, increased morbidity, and mortality, pose a significant burden on individuals and healthcare systems. Evidence has established that lifestyle and dietary modification are central to achieving effective weight loss. One approach shown to be efficacious in achieving weight loss is the use of a very low calorie ketogenic diet (VLCKD), which includes stages of induced ketosis, followed by a reintroduction to a low calorie diet and maintenance diet. Such regimens have been shown to result in sustained weight loss and, for some people, remission of Type 2 diabetes (T2D). A similar approach, which may also be a component of the VLCKD, is the use of total or partial replacement of meals using nutritionally complete shakes, bars, or soups. These may be combined with other weight loss measures, including bariatric surgery or medications. It is important that such programmes are delivered in a structured, medically-monitored, and supportive environment, such as laid out by Obesity Canada’s ‘5As’ programme. An ‘obesity shared medical appointment’ model is a multidisciplinary approach, whereby a patient with obesity is seen by a number of healthcare specialists, depending on their comorbidities. The patient also has the opportunity to meet with obesity specialists and engage in monthly patient support groups, all of which have been shown to be successful interventions in helping patients lead a healthier lifestyle, and gain more control over their weight. The following proceedings are based on talks given by leading obesity experts, presented at the 30th European Congress on Obesity (ECO 2023), which took place in Dublin, Republic of Ireland, in May 2023.","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136363153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sensitivity And Specificity of FEF25–75/Forced Vital Capacity for Diagnosing Restrictive Lung Disease FEF25-75 /用力肺活量诊断限制性肺疾病的敏感性和特异性
Pub Date : 2023-08-21 DOI: 10.33590/emj/10306372
Mohamad Reza Tarkhorani, Fateme Ziamanesh, Hosein Kazemi Zadeh, Maryam Edalatifard, Besharat Rahimi
Introduction and objective: The role of spirometry in the diagnosis of restrictive lung diseases is unclear. This study investigated the sensitivity and specificity of the forced expiratory flow 25–75 (FEF25–75)/forced vital capacity (FVC) parameter in diagnosing restrictive lung disease. Methods: In this study, the records of all restrictive patients who were referred to the pulmonary centre of Imam Khomeini Hospital, Tehran, Iran, from March 2021–March 2022 have been reviewed, and the indexes in the body box and spirometry have been recorded. Results: A total of 527 people were included in the study. Among them, 134 people (25.4%) had restrictive lung disease. The average area under the graph of the FEF25–75/FVC index is 0.648±0.028. It can be said that the area under the graph for the FEF25–75/FVC index is between 0.594–0.703. The FEF25–75/FVC index at values above 79.90 has a sensitivity of 70.9% and a false positive rate (1- specificity) of 53.2%. Conclusions: According to the result of this study, the ratio of FEF25–75/FVC index in spirometry at above 79.90 has a sensitivity of 70.9% and a false positive rate (1- specificity) of 53.2%. Therefore, it can be used as a screening test for restrictive lung diseases.
简介和目的:肺量测定在限制性肺疾病诊断中的作用尚不清楚。本研究探讨用力呼气流量25-75 (FEF25-75)/用力肺活量(FVC)参数诊断限制性肺疾病的敏感性和特异性。方法:回顾伊朗德黑兰伊玛目霍梅尼医院肺科中心于2021年3月至2022年3月转诊的所有限制性患者的病历,记录其体箱指标和肺活量测定指标。结果:共有527人被纳入研究。其中134人(25.4%)患有限制性肺部疾病。FEF25-75 /FVC指数图下平均面积为0.648±0.028。可以说,FEF25-75 /FVC指数的图下面积在0.594-0.703之间。FEF25-75 /FVC指数在79.90以上时,敏感性为70.9%,假阳性率(1-特异性)为53.2%。结论:本研究结果显示,肺活量测定中FEF25-75 /FVC指数比值在79.90以上时,敏感性为70.9%,假阳性率(1-特异性)为53.2%。因此,它可以作为限制性肺部疾病的筛查试验。
{"title":"Sensitivity And Specificity of FEF25–75/Forced Vital Capacity for Diagnosing Restrictive Lung Disease","authors":"Mohamad Reza Tarkhorani, Fateme Ziamanesh, Hosein Kazemi Zadeh, Maryam Edalatifard, Besharat Rahimi","doi":"10.33590/emj/10306372","DOIUrl":"https://doi.org/10.33590/emj/10306372","url":null,"abstract":"Introduction and objective: The role of spirometry in the diagnosis of restrictive lung diseases is unclear. This study investigated the sensitivity and specificity of the forced expiratory flow 25–75 (FEF25–75)/forced vital capacity (FVC) parameter in diagnosing restrictive lung disease. Methods: In this study, the records of all restrictive patients who were referred to the pulmonary centre of Imam Khomeini Hospital, Tehran, Iran, from March 2021–March 2022 have been reviewed, and the indexes in the body box and spirometry have been recorded. Results: A total of 527 people were included in the study. Among them, 134 people (25.4%) had restrictive lung disease. The average area under the graph of the FEF25–75/FVC index is 0.648±0.028. It can be said that the area under the graph for the FEF25–75/FVC index is between 0.594–0.703. The FEF25–75/FVC index at values above 79.90 has a sensitivity of 70.9% and a false positive rate (1- specificity) of 53.2%. Conclusions: According to the result of this study, the ratio of FEF25–75/FVC index in spirometry at above 79.90 has a sensitivity of 70.9% and a false positive rate (1- specificity) of 53.2%. Therefore, it can be used as a screening test for restrictive lung diseases.","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"97 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135817574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interview: Dirk Devroey 采访:Dirk Devroey
Pub Date : 2023-08-15 DOI: 10.33590/emj/10304915
Dirk Devroey
{"title":"Interview: Dirk Devroey","authors":"Dirk Devroey","doi":"10.33590/emj/10304915","DOIUrl":"https://doi.org/10.33590/emj/10304915","url":null,"abstract":"","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135114322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infographic: The Backbone of Mobility: Interconnected Musculoskeletal Health 信息图:活动的骨干:相互联系的肌肉骨骼健康
Pub Date : 2023-06-15 DOI: 10.33590/emj/10306291.
{"title":"Infographic: The Backbone of Mobility: Interconnected Musculoskeletal Health","authors":"","doi":"10.33590/emj/10306291.","DOIUrl":"https://doi.org/10.33590/emj/10306291.","url":null,"abstract":"","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"54 33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135859540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis. 系统性硬化症患者胃肠道微生物组的纵向特征。
Pub Date : 2020-12-10 DOI: 10.33590/emj/20-00043
Elizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, Venu Lagishetty, Philip J Clements, Øyvind Midtvedt, Øyvind Molberg, Jonathan Braun, Jonathan P Jacobs

Objectives: To evaluate changes in microbial composition and the evolution of gastrointestinal tract (GIT) symptoms in systemic sclerosis (SSc).

Methods: Adult SSc patients provided stool specimens every 3 months over the course of 1 year. Participants completed the University of California, Los Angeles (UCLA) GIT 2.0 questionnaire to assess GIT symptom severity at each stool collection. The microbiota from these samples were determined by Illumina HiSeq 2500 16S ribosomal RNA sequencing (Illumina, Inc., San Diego, California, USA). Mixed effect models evaluated changes in GIT symptoms and microbial composition over time.

Results: Among 19 patients with SSc (female; 89.5%; median age: 51.3 years), the median disease duration was 7 years and the baseline total GIT 2.0 score was 0.7 (standard deviation: 0.6). The majority of participants (63%) provided at least four stool samples over the course of the 12-month study. Patients with longer disease durations had increased GIT symptoms over the course of the study. There was no difference in the course of GIT symptoms over time between patients with limited versus diffuse cutaneous disease. The relative abundances of specific genera did not change over time within individual subjects. After controlling for age, sex, ethnicity, disease duration, and SSc subtype (i.e., limited versus diffuse), low abundance of Bacteroides was associated with increased GIT symptoms over time.

Conclusion: This study is the first to have longitudinally characterised the lower GIT microbiome in SSc patients and demonstrated relative stability of genera abundance over the course of 1 year. The findings provide additional evidence that specific genera are associated with SSc-GIT symptoms and warrant further evaluation in larger SSc studies.

目的:评估系统性硬化症(SSc)患者胃肠道(GIT)症状的微生物组成变化:评估系统性硬化症(SSc)患者微生物组成的变化和胃肠道(GIT)症状的演变:成年 SSc 患者在一年内每 3 个月提供一次粪便标本。参与者填写加州大学洛杉矶分校(UCLA)GIT 2.0 问卷,以评估每次采集粪便时 GIT 症状的严重程度。这些样本中的微生物群通过 Illumina HiSeq 2500 16S 核糖体 RNA 测序(Illumina 公司,美国加利福尼亚州圣迭戈)进行测定。混合效应模型评估了胃肠道症状和微生物组成随时间的变化:在 19 名 SSc 患者(女性;89.5%;中位年龄:51.3 岁)中,中位病程为 7 年,基线 GIT 2.0 总分为 0.7(标准差:0.6)。大多数参与者(63%)在为期 12 个月的研究过程中至少提供了四份粪便样本。病程较长的患者在研究过程中出现的胃肠道症状有所增加。局限性与弥漫性皮肤病患者的消化道症状在时间上没有差异。在个体受试者中,特定菌属的相对丰度并没有随着时间的推移而发生变化。在控制了年龄、性别、种族、病程和 SSc 亚型(即局限性与弥漫性)之后,随着时间的推移,低丰度的 Bacteroides 与 GIT 症状的增加有关:本研究首次纵向描述了 SSc 患者下消化道微生物组的特征,并证明了 1 年内菌属丰度的相对稳定性。这些发现提供了更多证据,证明特定菌属与 SSc-GIT 症状有关,值得在更大规模的 SSc 研究中进一步评估。
{"title":"Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis.","authors":"Elizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, Venu Lagishetty, Philip J Clements, Øyvind Midtvedt, Øyvind Molberg, Jonathan Braun, Jonathan P Jacobs","doi":"10.33590/emj/20-00043","DOIUrl":"10.33590/emj/20-00043","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate changes in microbial composition and the evolution of gastrointestinal tract (GIT) symptoms in systemic sclerosis (SSc).</p><p><strong>Methods: </strong>Adult SSc patients provided stool specimens every 3 months over the course of 1 year. Participants completed the University of California, Los Angeles (UCLA) GIT 2.0 questionnaire to assess GIT symptom severity at each stool collection. The microbiota from these samples were determined by Illumina HiSeq 2500 16S ribosomal RNA sequencing (Illumina, Inc., San Diego, California, USA). Mixed effect models evaluated changes in GIT symptoms and microbial composition over time.</p><p><strong>Results: </strong>Among 19 patients with SSc (female; 89.5%; median age: 51.3 years), the median disease duration was 7 years and the baseline total GIT 2.0 score was 0.7 (standard deviation: 0.6). The majority of participants (63%) provided at least four stool samples over the course of the 12-month study. Patients with longer disease durations had increased GIT symptoms over the course of the study. There was no difference in the course of GIT symptoms over time between patients with limited versus diffuse cutaneous disease. The relative abundances of specific genera did not change over time within individual subjects. After controlling for age, sex, ethnicity, disease duration, and SSc subtype (i.e., limited versus diffuse), low abundance of <i>Bacteroides</i> was associated with increased GIT symptoms over time.</p><p><strong>Conclusion: </strong>This study is the first to have longitudinally characterised the lower GIT microbiome in SSc patients and demonstrated relative stability of genera abundance over the course of 1 year. The findings provide additional evidence that specific genera are associated with SSc-GIT symptoms and warrant further evaluation in larger SSc studies.</p>","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"7 ","pages":"110-118"},"PeriodicalIF":0.0,"publicationDate":"2020-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881192/pdf/nihms-1854426.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9157458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Differences in Paediatric and Adult Asthma 儿童和成人哮喘的性别差异
Pub Date : 2019-06-01 DOI: 10.33590/emj/10312930
Anika Naeem, P. Silveyra
Asthma is the most common chronic condition in Western countries. Affecting 1 in 7 children and 1 in 12 adults, asthma is responsible for >350,000 avoidable deaths every year. While most children who develop symptoms of asthma are <5 years of age, the disease is frequently misdiagnosed or not suspected in infants and toddlers. In addition, the prevalence of asthma is different in males and females throughout their lifespan. While boys are more likely to develop asthma than girls, this pattern is reversed after puberty. This indicates that sex-specific factors, such as fluctuations in hormone levels, play a role in the disease’s pathogenesis. In this review, the authors discuss recent advances in diagnostic tools for asthma in both adults and children, as well as the influences of BMI, environmental exposures, socioeconomic factors, and sex hormones in the disease’s pathogenesis. The review will show that both experimental and epidemiological evidence suggest that circulating sex hormone levels are important contributors to asthma symptoms in post-pubertal females, while their role in males and children has not been yet established. In addition, the mechanisms associated with these hormonal influences on airway inflammation and hyper-reactivity have not been yet elucidated. The authors conclude that different factors affect asthma rates and severity in children and adults, and that more research needs to be conducted to identify the specific contributions of sex hormones. These will allow the development of more personalised asthma treatment strategies for men and women at different stages of life.
哮喘是西方国家最常见的慢性疾病。哮喘影响七分之一的儿童和十二分之一的成人,每年造成35万例本可避免的死亡。虽然大多数出现哮喘症状的儿童年龄小于5岁,但婴儿和学步儿童经常被误诊或未被怀疑患有该病。此外,哮喘的患病率在男性和女性的一生中是不同的。虽然男孩比女孩更容易患哮喘,但这种模式在青春期后就会逆转。这表明,性别特异性因素,如激素水平的波动,在疾病的发病机制中起作用。在这篇综述中,作者讨论了成人和儿童哮喘诊断工具的最新进展,以及BMI、环境暴露、社会经济因素和性激素在疾病发病机制中的影响。该综述将表明,实验和流行病学证据都表明,循环性激素水平是青春期后女性哮喘症状的重要因素,而其在男性和儿童中的作用尚未确定。此外,这些激素对气道炎症和高反应性影响的相关机制尚未阐明。作者得出结论,不同的因素影响儿童和成人哮喘的发病率和严重程度,需要进行更多的研究来确定性激素的具体作用。这将允许针对不同生命阶段的男性和女性开发更个性化的哮喘治疗策略。
{"title":"Sex Differences in Paediatric and Adult Asthma","authors":"Anika Naeem, P. Silveyra","doi":"10.33590/emj/10312930","DOIUrl":"https://doi.org/10.33590/emj/10312930","url":null,"abstract":"Asthma is the most common chronic condition in Western countries. Affecting 1 in 7 children and 1 in 12 adults, asthma is responsible for >350,000 avoidable deaths every year. While most children who develop symptoms of asthma are <5 years of age, the disease is frequently misdiagnosed or not suspected in infants and toddlers. In addition, the prevalence of asthma is different in males and females throughout their lifespan. While boys are more likely to develop asthma than girls, this pattern is reversed after puberty. This indicates that sex-specific factors, such as fluctuations in hormone levels, play a role in the disease’s pathogenesis. In this review, the authors discuss recent advances in diagnostic tools for asthma in both adults and children, as well as the influences of BMI, environmental exposures, socioeconomic factors, and sex hormones in the disease’s pathogenesis. The review will show that both experimental and epidemiological evidence suggest that circulating sex hormone levels are important contributors to asthma symptoms in post-pubertal females, while their role in males and children has not been yet established. In addition, the mechanisms associated with these hormonal influences on airway inflammation and hyper-reactivity have not been yet elucidated. The authors conclude that different factors affect asthma rates and severity in children and adults, and that more research needs to be conducted to identify the specific contributions of sex hormones. These will allow the development of more personalised asthma treatment strategies for men and women at different stages of life.","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"105 1","pages":"27 - 35"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78513362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
OCCUPATIONAL ALLERGY. 职业过敏。
Stacey E Anderson, Carrie Long, G Scott Dotson

An estimated 11 million workers in the USA are potentially exposed to agents that can become a cause of allergic diseases such as occupational asthma and allergic contact dermatitis, which can adversely affect health and well-being. Hundreds of chemicals (e.g. metals, epoxy and acrylic resins, rubber additives, and chemical intermediates) and proteins (e.g. natural rubber latex, plant proteins, mould, animal dander) present in virtually every industry have been identified as causes of allergic disease. In general, allergens can be classified as low molecular weight (chemical) allergens and high molecular weight (protein) allergens. These agents are capable of inducing immunological responses that are both immunoglobulin E and non-immunoglobulin E-mediated. Interestingly, the same chemical can induce diverse immune responses in different individuals. As new hazards continue to emerge, it is critical to understand the immunological mechanisms of occupational allergic disease. Specific understanding of these mechanisms has direct implications in hazard identification, hazard communication, and risk assessment. Such efforts will ultimately assist in the development of risk management strategies capable of controlling workplace exposures to allergens to prevent the induction of sensitisation in naïve individuals and inhibit elicitation of allergic responses. The purpose of this short review is to give a brief synopsis of the incidence, agents, mechanisms, and research needs related to occupational allergy.

据估计,美国有1100万工人可能接触到可能导致过敏性疾病的物质,如职业性哮喘和过敏性接触性皮炎,这些疾病会对健康和福祉产生不利影响。几乎每个行业中存在的数百种化学品(例如金属、环氧树脂和丙烯酸树脂、橡胶添加剂和化学中间体)和蛋白质(例如天然胶乳、植物蛋白、霉菌、动物皮屑)已被确定为过敏性疾病的原因。一般来说,过敏原可分为低分子量(化学)过敏原和高分子量(蛋白质)过敏原。这些药物能够诱导免疫球蛋白E和非免疫球蛋白E介导的免疫反应。有趣的是,同一种化学物质可以在不同的个体中诱导不同的免疫反应。随着新的危害不断出现,了解职业性变态反应性疾病的免疫学机制至关重要。对这些机制的具体理解对危害识别、危害沟通和风险评估具有直接意义。这些努力最终将有助于制定能够控制工作场所接触过敏原的风险管理战略,以防止naïve个人的致敏,并抑制过敏反应的引发。本文就职业性过敏的发病率、诱发因素、机制和研究需要作一简要综述。
{"title":"OCCUPATIONAL ALLERGY.","authors":"Stacey E Anderson, Carrie Long, G Scott Dotson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>An estimated 11 million workers in the USA are potentially exposed to agents that can become a cause of allergic diseases such as occupational asthma and allergic contact dermatitis, which can adversely affect health and well-being. Hundreds of chemicals (e.g. metals, epoxy and acrylic resins, rubber additives, and chemical intermediates) and proteins (e.g. natural rubber latex, plant proteins, mould, animal dander) present in virtually every industry have been identified as causes of allergic disease. In general, allergens can be classified as low molecular weight (chemical) allergens and high molecular weight (protein) allergens. These agents are capable of inducing immunological responses that are both immunoglobulin E and non-immunoglobulin E-mediated. Interestingly, the same chemical can induce diverse immune responses in different individuals. As new hazards continue to emerge, it is critical to understand the immunological mechanisms of occupational allergic disease. Specific understanding of these mechanisms has direct implications in hazard identification, hazard communication, and risk assessment. Such efforts will ultimately assist in the development of risk management strategies capable of controlling workplace exposures to allergens to prevent the induction of sensitisation in naïve individuals and inhibit elicitation of allergic responses. The purpose of this short review is to give a brief synopsis of the incidence, agents, mechanisms, and research needs related to occupational allergy.</p>","PeriodicalId":72984,"journal":{"name":"European Medical Journal (Chelmsford, England)","volume":"2 2","pages":"65-71"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454566/pdf/nihms-1019260.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37321368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Medical Journal (Chelmsford, England)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1